PROCESSA PHARMACEUTICALS PROVIDES SHAREHOLDER UPDATE
25. Februar 2020 09:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing drugs to improve the survival and/or quality of...